Taipa, Macao

Jing-Rong Wang


Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Macau, CN (2019 - 2021)
  • Taipa, MO (2017 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Jing-Rong Wang

Introduction

Jing-Rong Wang is a notable inventor based in Taipa, Macau. He has made significant contributions to the field of biomedical research, particularly in the area of sphingolipids and autoimmune diseases. With a total of seven patents to his name, Wang's work has the potential to impact therapeutic approaches for various inflammatory conditions.

Latest Patents

Wang's latest patents include a method of isolating sphingolipids from cordyceps and their use. This innovative method allows for the extraction of specific sphingolipid portions, which have shown exceptional immunosuppressive activities. Additionally, he has developed a method for treating subjects suffering from inflammatory diseases, including autoimmune and allergic diseases, by administering these isolated sphingolipids. Another significant patent involves the use of glycan biomarkers for determining the presence of autoimmune diseases, along with a method to improve the detection sensitivity of trace glycans using a microfluidic chip.

Career Highlights

Jing-Rong Wang is affiliated with the Macau University of Science and Technology, where he conducts his research and develops his inventions. His work has garnered attention for its innovative approaches to complex health issues, particularly in the realm of immunology and disease treatment.

Collaborations

Wang has collaborated with notable colleagues such as Zhi-Hong Jiang and Guo-Yuan Zhu, contributing to the advancement of research in his field.

Conclusion

Jing-Rong Wang's contributions to the field of biomedical research through his patents and innovative methods highlight his role as a leading inventor. His work not only advances scientific understanding but also offers potential solutions for treating autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…